336 related articles for article (PubMed ID: 26319099)
21. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
[TBL] [Abstract][Full Text] [Related]
22. Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives.
Tung KH; Goodman MT; Wu AH; McDuffie K; Wilkens LR; Nomura AM; Kolonel LN
Am J Epidemiol; 2004 Apr; 159(8):750-8. PubMed ID: 15051584
[TBL] [Abstract][Full Text] [Related]
23. Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Wentzensen N; Black A; Jacobs K; Yang HP; Berg CD; Caporaso N; Peters U; Ragard L; Buys SS; Chanock S; Hartge P
PLoS One; 2011; 6(7):e21731. PubMed ID: 21750727
[TBL] [Abstract][Full Text] [Related]
24. A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors.
Schmidt M; Hellwig B; Hammad S; Othman A; Lohr M; Chen Z; Boehm D; Gebhard S; Petry I; Lebrecht A; Cadenas C; Marchan R; Stewart JD; Solbach C; Holmberg L; Edlund K; Kultima HG; Rody A; Berglund A; Lambe M; Isaksson A; Botling J; Karn T; Müller V; Gerhold-Ay A; Cotarelo C; Sebastian M; Kronenwett R; Bojar H; Lehr HA; Sahin U; Koelbl H; Gehrmann M; Micke P; Rahnenführer J; Hengstler JG
Clin Cancer Res; 2012 May; 18(9):2695-703. PubMed ID: 22351685
[TBL] [Abstract][Full Text] [Related]
25. The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study.
Carere DA; VanderWeele T; Moreno TA; Mountain JL; Roberts JS; Kraft P; Green RC;
BMC Med Genomics; 2015 Oct; 8():63. PubMed ID: 26468061
[TBL] [Abstract][Full Text] [Related]
26. Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer.
Timofeeva MN; Kinnersley B; Farrington SM; Whiffin N; Palles C; Svinti V; Lloyd A; Gorman M; Ooi LY; Hosking F; Barclay E; Zgaga L; Dobbins S; Martin L; Theodoratou E; Broderick P; Tenesa A; Smillie C; Grimes G; Hayward C; Campbell A; Porteous D; Deary IJ; Harris SE; Northwood EL; Barrett JH; Smith G; Wolf R; Forman D; Morreau H; Ruano D; Tops C; Wijnen J; Schrumpf M; Boot A; Vasen HF; Hes FJ; van Wezel T; Franke A; Lieb W; Schafmayer C; Hampe J; Buch S; Propping P; Hemminki K; Försti A; Westers H; Hofstra R; Pinheiro M; Pinto C; Teixeira M; Ruiz-Ponte C; Fernández-Rozadilla C; Carracedo A; Castells A; Castellví-Bel S; Campbell H; Bishop DT; Tomlinson IP; Dunlop MG; Houlston RS
Sci Rep; 2015 Nov; 5():16286. PubMed ID: 26553438
[TBL] [Abstract][Full Text] [Related]
27. Searching for microsatellite mutations in coding regions in lung, breast, ovarian and colorectal cancers.
Forgacs E; Wren JD; Kamibayashi C; Kondo M; Xu XL; Markowitz S; Tomlinson GE; Muller CY; Gazdar AF; Garner HR; Minna JD
Oncogene; 2001 Feb; 20(8):1005-9. PubMed ID: 11314036
[TBL] [Abstract][Full Text] [Related]
28. Genetic associations of breast and prostate cancer are enriched for regulatory elements identified in disease-related tissues.
Chen H; Kichaev G; Bien SA; MacDonald JW; Wang L; Bammler TK; Auer P; Pasaniuc B; Lindström S
Hum Genet; 2019 Oct; 138(10):1091-1104. PubMed ID: 31230194
[TBL] [Abstract][Full Text] [Related]
29. Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.
Pande M; Joon A; Brewster AM; Chen WV; Hopper JL; Eng C; Shete S; Casey G; Schumacher F; Lin Y; Harrison TA; White E; Ahsan H; Andrulis IL; Whittemore AS; John EM; Ko Win A; Makalic E; Schmidt DF; Kapuscinski MK; Ochs-Balcom HM; Gallinger S; Jenkins MA; Newcomb PA; Lindor NM; Peters U; Amos CI; Lynch PM
PLoS One; 2018; 13(4):e0196245. PubMed ID: 29698419
[TBL] [Abstract][Full Text] [Related]
30. P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.
Lasky T; Silbergeld E
Environ Health Perspect; 1996 Dec; 104(12):1324-31. PubMed ID: 9118874
[TBL] [Abstract][Full Text] [Related]
31. Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia.
Cheng I; Kocarnik JM; Dumitrescu L; Lindor NM; Chang-Claude J; Avery CL; Caberto CP; Love SA; Slattery ML; Chan AT; Baron JA; Hindorff LA; Park SL; Schumacher FR; Hoffmeister M; Kraft P; Butler AM; Duggan DJ; Hou L; Carlson CS; Monroe KR; Lin Y; Carty CL; Mann S; Ma J; Giovannucci EL; Fuchs CS; Newcomb PA; Jenkins MA; Hopper JL; Haile RW; Conti DV; Campbell PT; Potter JD; Caan BJ; Schoen RE; Hayes RB; Chanock SJ; Berndt SI; Küry S; Bézieau S; Ambite JL; Kumaraguruparan G; Richardson DM; Goodloe RJ; Dilks HH; Baker P; Zanke BW; Lemire M; Gallinger S; Hsu L; Jiao S; Harrison TA; Seminara D; Haiman CA; Kooperberg C; Wilkens LR; Hutter CM; White E; Crawford DC; Heiss G; Hudson TJ; Brenner H; Bush WS; Casey G; Le Marchand L; Peters U
Gut; 2014 May; 63(5):800-7. PubMed ID: 23935004
[TBL] [Abstract][Full Text] [Related]
32. Genetic and familial factors influencing breast, colon, prostate and lung cancers.
Stein QP; Flanagan JD
S D Med; 2010; Spec No():16-22. PubMed ID: 20397487
[TBL] [Abstract][Full Text] [Related]
33. Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer.
Vahid S; Thaper D; Gibson KF; Bishop JL; Zoubeidi A
Sci Rep; 2016 Aug; 6():31842. PubMed ID: 27555231
[TBL] [Abstract][Full Text] [Related]
34. Frequency of Smad gene mutations in human cancers.
Riggins GJ; Kinzler KW; Vogelstein B; Thiagalingam S
Cancer Res; 1997 Jul; 57(13):2578-80. PubMed ID: 9205057
[TBL] [Abstract][Full Text] [Related]
35. White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).
Sturgeon SR; Pilsner JR; Arcaro KF; Ikuma K; Wu H; Kim SM; Chopra-Tandon N; Karpf AR; Ziegler RG; Schairer C; Balasubramanian R; Reckhow DA
Breast Cancer Res; 2017 Aug; 19(1):94. PubMed ID: 28821281
[TBL] [Abstract][Full Text] [Related]
36. Pan-cancer and cross-population genome-wide association studies dissect shared genetic backgrounds underlying carcinogenesis.
Sato G; Shirai Y; Namba S; Edahiro R; Sonehara K; Hata T; Uemura M; ; Matsuda K; Doki Y; Eguchi H; Okada Y
Nat Commun; 2023 Jun; 14(1):3671. PubMed ID: 37340002
[TBL] [Abstract][Full Text] [Related]
37. A review of the cost-effectiveness of genetic testing for germline variants in familial cancer.
Teppala S; Hodgkinson B; Hayes S; Scuffham P; Tuffaha H
J Med Econ; 2023; 26(1):19-33. PubMed ID: 36426964
[TBL] [Abstract][Full Text] [Related]
38. A cis-eQTL genetic variant of the cancer-testis gene CCDC116 is associated with risk of multiple cancers.
Qin N; Wang C; Lu Q; Huang T; Zhu M; Wang L; Yu F; Huang M; Jiang Y; Dai J; Ma H; Jin G; Wu C; Lin D; Shen H; Hu Z
Hum Genet; 2017 Aug; 136(8):987-997. PubMed ID: 28653172
[TBL] [Abstract][Full Text] [Related]
39. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
Lin E; Li L; Guan Y; Soriano R; Rivers CS; Mohan S; Pandita A; Tang J; Modrusan Z
Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of AGR2 expression in solid tumours: a systematic review and meta-analysis.
Tian SB; Tao KX; Hu J; Liu ZB; Ding XL; Chu YN; Cui JY; Shuai XM; Gao JB; Cai KL; Wang JL; Wang GB; Wang L; Wang Z
Sci Rep; 2017 Nov; 7(1):15500. PubMed ID: 29138453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
